
Chandan Kumar Srivastav
About Chandan Kumar Srivastav
Data last updated:
Chandan Kumar Srivastav is a Director at David Sun Pharmaceuticals Private Limited (since 2021). The company operates in Food And Beverages. David Sun Pharmaceuticals Private Limited reported revenue of ₹52,857 (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Sep 2021 | 2020 | ₹52,857 (FY 2022) | Active |
Board colleagues of Chandan Kumar Srivastav
| Name | DIN | Company | Designation |
|---|---|---|---|
| Himanshu Srivastava | 08848388 | David Sun Pharmaceuticals Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandan Kumar Srivastav
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandan Kumar Srivastav
Chandan Kumar Srivastav currently holds 1 directorship: David Sun Pharmaceuticals Private Limited (Director, since 01 Sep 2021, revenue ₹52,857 (FY 2022)).
Chandan Kumar Srivastav was first appointed on 01 Sep 2021 as Director at David Sun Pharmaceuticals Private Limited.
The current boards of Chandan Kumar Srivastav's companies include Himanshu Srivastava (David Sun Pharmaceuticals Private Limited).